Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings

Front Psychiatry. 2024 Feb 16:15:1372373. doi: 10.3389/fpsyt.2024.1372373. eCollection 2024.

¹ Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.
² Department of Psychology, Yale University, New Haven, CT, United States.
³ Center for Brain and Mind Health, Yale University School of Medicine, New Haven, CT, United States.
⁴ Child Study Center, Yale University School of Medicine, New Haven, CT, United States.

Abstract

[This corrects the article DOI: 10.3389/fpsyt.2023.1278823.].

Keywords: adult psychiatry; mental health; non-directive support; obsessive-compulsive disorder; psilocybin; psychedelic; treatment; waitlist.